6:29 PM · 23 April 2020

BREAKING : Strong declines on Wall Street - Gilead drug rejected in phase I testing

In the last minutes we have been observing a strong declines on Wall Street. This is linked to recent rumors that a Gilead drug called Remdesivir, which showed the most promising initial results in the treatment of  coronavirus, was rejected in phase I tests. S&P 500 retreats from around 2830 points, below 2790 points. Gilead's stock is currently losing 2%. This information was provided by the Financial Times.
S&P 500 dropped sharpy lower after information regarding coronavirus drug hit the markets. Source: xStation5
14 July 2026, 7:12 AM

Morning Wrap: US Indices rise ahead of CPI and Fed Chair Warsh speech (14.07.2026)

13 July 2026, 3:01 PM

US OPEN: Capital is once again fleeing “memory stocks”; Wall Street under pressure at the open 🚨

13 July 2026, 11:21 AM

Market Wrap: Geopolitical déjà vu. Hormuz once again in the center of investors' attention.

13 July 2026, 7:19 AM

Morning Wrap: Strait of Hormuz Closed? (13.07.2026)

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits